News & Updates

Show Multimedia Only
GLP-1RAs reduce weight in overweight/obese individuals without diabetes

GLP-1RAs reduce weight in overweight/obese individuals without diabetes

30 Sep 2023 byStephen Padilla

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in significant weight loss in patients with obesity or overweight without diabetes, a study has shown. In addition, the best GLP-1RA agent appears to be semaglutide, showing superior efficacy and low-to-moderate risk of side effects.

GLP-1RAs reduce weight in overweight/obese individuals without diabetes

30 Sep 2023
Lorundrostat may expand treatment toolbox for uncontrolled hypertension

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

29 Sep 2023
Pretreatment serum CEA level predicts survival in NSCLC

Pretreatment serum CEA level predicts survival in NSCLC

29 Sep 2023